Rankings
▼
Calendar
BBOT FY 2021 Earnings — BridgeBio Oncology Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BBOT
BridgeBio Oncology Therapeutics Inc.
$820M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$43,357
Net Income
-$43,357
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$144,281
Total Liabilities
$162,638
Stockholders' Equity
-$18,357
Cash & Equivalents
$0
← FY 2022
All Quarters
